Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-385
Closed -$24K 374
2022
Q3
$24K Hold
385
0.01% 408
2022
Q2
$26K Hold
385
0.01% 384
2022
Q1
$29K Buy
385
+365
+1,825% +$26.2K 0.01% 388
2021
Q4
$1K Sell
20
-25
-56% -$1.84K ﹤0.01% 721
2021
Q3
$3K Hold
45
﹤0.01% 715
2021
Q2
$3K Hold
45
﹤0.01% 685
2021
Q1
$3K Buy
45
+25
+125% +$1.9K ﹤0.01% 668
2020
Q4
$1K Hold
20
﹤0.01% 727
2020
Q3
$1K Hold
20
﹤0.01% 706
2020
Q2
$1K Buy
+20
New +$981 ﹤0.01% 685

Other funds holding HOLX

Hudock Inc's HOLX Position: Q4 2022 in Review

Hudock Inc sold out of Hologic (HOLX) in Q4 2022, closing a stake of 385 shares — an estimated $24K sold.

Hudock Inc first reported a position in HOLX in Q2 2020 and held it in 10 quarters. The position peaked at $29K in Q1 2022. 697 funds tracked by Wall St. Rank hold HOLX as of Q4 2022.

  • Hudock Inc reported no remaining Hologic position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 385 Hologic shares in Q4 2022, an estimated $24K.
  • Hudock Inc first reported a position in Hologic in Q2 2020 and held it in 10 quarters.
  • Hudock Inc's Hologic position peaked at $29K in Q1 2022.
  • 697 funds tracked by Wall St. Rank held Hologic as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.